Rodney L Eisenberg

Title: Innovations by Rodney L Eisenberg

Introduction

Rodney L Eisenberg is an accomplished inventor based in Richmond, KY (US). He has made significant contributions to the field of biotechnology, particularly in the area of blood clot management. With a total of 2 patents to his name, Eisenberg's work focuses on innovative methods for delivering protease inhibitors.

Latest Patents

Eisenberg's latest patents include a system and method for delivering protease inhibitors. This invention provides a means of artificially retarding fibrin-based blood clot degradation through the sustained release of a protease inhibitor, such as aprotinin or tranexamic acid (TA). The sustained release is achieved by incorporating the inhibitor within a biodegradable polymer microsphere, creating a specialized formulation. This formulation, along with fibrinogen and thrombin, is applied to a wound site. The outer surface of the polymer microsphere degrades in a proteolytic environment, releasing the incorporated protease inhibitor to the surrounding hydrogel or sealant at the wound site.

Career Highlights

Eisenberg is currently associated with Bordoloi Biotech, LLC, where he continues to develop innovative solutions in biotechnology. His work has the potential to significantly impact medical practices related to wound care and blood clot management.

Collaborations

Eisenberg collaborates with notable colleagues, including Binoy K Bordoloi and Nayan J Sarma. Their combined expertise contributes to the advancement of their projects and the overall mission of Bordoloi Biotech, LLC.

Conclusion

Rodney L Eisenberg's contributions to the field of biotechnology through his innovative patents demonstrate his commitment to improving medical treatments. His work in developing systems for delivering protease inhibitors showcases the potential for advancements in wound care and blood clot management.